A dynorphin peptide induces hypotension by stimulating the release of atrial natriuretic peptide from rat atrium
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (11) , 1117-1122
- https://doi.org/10.1016/0024-3205(88)90605-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The morphine effect on plasma ANFEuropean Journal of Pharmacology, 1986
- Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of α- and β-adrenergic and cholinergic agonists on plasma and atrial ANF in the ratBiochemical and Biophysical Research Communications, 1986
- Alpha-human atrial natriuretic polypeptide (Alpha-hANP) in normal volunteers and patients with heart failure or hypertensionPeptides, 1986
- Depressor and natriuretic activities of several atrial peptidesRegulatory Peptides, 1984
- Purification and Sequence Analysis of Bioactive Atrial Peptides (Atriopeptins)Science, 1984
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- The amino acid sequence of an atrial peptide with potent diuretic and natriuretic propertiesBiochemical and Biophysical Research Communications, 1983
- Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian AtriaScience, 1983
- Dynorphin(1–10)amide: A potent and selective analog of dynorphin(1–13)Life Sciences, 1982
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979